TP53 and breast carcinoma: In line with findings from other solid tumours, the p53 null pattern in TNBC should not be simply classified as ‘p53‐negative’ based on usual cutoffs (e.g. less than 1% or 10% expression commonly used in breast cancer).10, 36, 37